Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,075 | 119 | 67.2% |
| Consulting Fee | $1,000 | 1 | 32.4% |
| Education | $12.51 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,168 | 14 | $0 (2021) |
| AbbVie Inc. | $399.97 | 20 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $215.66 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $212.94 | 13 | $0 (2022) |
| Lilly USA, LLC | $145.41 | 9 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $116.59 | 6 | $0 (2023) |
| PFIZER INC. | $102.32 | 6 | $0 (2022) |
| GENZYME CORPORATION | $72.44 | 3 | $0 (2023) |
| Celgene Corporation | $69.11 | 4 | $0 (2018) |
| LEO Pharma Inc. | $58.42 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.28 | 5 | Arcutis Biotherapeutics, Inc. ($24.95) |
| 2023 | $259.31 | 11 | AbbVie Inc. ($82.38) |
| 2022 | $198.15 | 10 | ABBVIE INC. ($92.02) |
| 2021 | $205.01 | 12 | AbbVie Inc. ($60.82) |
| 2020 | $107.49 | 6 | Ortho Dermatologics, a division of Bausch Health US, LLC ($22.77) |
| 2019 | $1,320 | 22 | Allergan Inc. ($1,061) |
| 2018 | $472.11 | 30 | Novartis Pharmaceuticals Corporation ($64.58) |
| 2017 | $441.22 | 25 | Novartis Pharmaceuticals Corporation ($83.54) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: DERMATOLOGY | ||||||
| 01/19/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Dermatology | ||||||
| 01/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Dermatology | ||||||
| 06/29/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.59 | General |
| Category: Immunology | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $38.93 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
| 03/27/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Inflammation | ||||||
| 03/03/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
| 01/31/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.20 | General |
| 11/16/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: Dermatology | ||||||
| 06/08/2022 | Incyte Corporation | OPZELURA (Drug) | Education | Cash or cash equivalent | $12.51 | General |
| Category: Dermatology | ||||||
| 05/10/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Immunology | ||||||
| 04/19/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,231 | 10,364 | $1.5M | $477,977 |
| 2022 | 28 | 5,528 | 9,224 | $1.3M | $420,226 |
| 2021 | 25 | 3,441 | 5,546 | $807,275 | $273,613 |
| 2020 | 27 | 3,563 | 6,039 | $859,255 | $276,984 |
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,025 | 1,441 | $260,821 | $89,281 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 780 | 879 | $226,782 | $74,487 | 32.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 848 | 989 | $249,228 | $65,758 | 26.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 613 | 773 | $162,330 | $63,884 | 39.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,016 | 1,376 | $195,392 | $48,067 | 24.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 100 | 104 | $59,488 | $24,046 | 40.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 274 | 274 | $61,102 | $20,350 | 33.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 709 | 3,457 | $86,425 | $17,163 | 19.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 205 | 293 | $39,848 | $11,357 | 28.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 16 | 30 | $14,760 | $8,884 | 60.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 78 | 84 | $36,540 | $7,869 | 21.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 48 | $14,880 | $6,267 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $15,318 | $5,211 | 34.0% |
| 69100 | Biopsy of ear | Office | 2023 | 78 | 85 | $27,795 | $4,676 | 16.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $9,684 | $4,427 | 45.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 109 | 109 | $15,805 | $4,223 | 26.7% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 12 | 13 | $8,970 | $3,961 | 44.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 28 | 28 | $13,440 | $2,955 | 22.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 31 | $9,827 | $2,844 | 28.9% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 13 | 26 | $5,850 | $2,713 | 46.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 20 | $7,680 | $2,599 | 33.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 55 | $6,160 | $2,106 | 34.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 40 | 62 | $6,448 | $2,095 | 32.5% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $5,993 | $1,223 | 20.4% |
| 11403 | Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $4,608 | $878.35 | 19.1% |
About Dr. Marcus Stonecipher, MD
Dr. Marcus Stonecipher, MD is a Dermatology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801904354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marcus Stonecipher, MD has received a total of $3,087 in payments from pharmaceutical and medical device companies, with $84.28 received in 2024. These payments were reported across 121 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,075).
As a Medicare-enrolled provider, Stonecipher has provided services to 18,763 Medicare beneficiaries, totaling 31,173 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Decatur, GA
- Active Since 08/25/2006
- Last Updated 05/22/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801904354
Products in Payments
- COSENTYX (Biological) $195.27
- TALTZ (Drug) $145.41
- SKYRIZI (Biological) $142.28
- STELARA (Biological) $127.39
- Humira (Biological) $109.78
- EUCRISA (Drug) $102.32
- BOTOX COSMETIC (Biological) $93.45
- DUPIXENT (Biological) $70.24
- Otezla (Drug) $69.11
- BOTOX (Biological) $57.85
- DUPIXENT DUPILUMAB INJECTION (Biological) $57.66
- Enbrel (Biological) $55.36
- Veltin (Drug) $55.08
- RINVOQ (Biological) $48.33
- OPZELURA (Drug) $45.83
- HUMIRA (Biological) $44.84
- TREMFYA (Drug) $42.82
- REMICADE (Biological) $42.73
- ClosureFast (Device) $41.97
- ADBRY (Biological) $40.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Decatur
Dr. Kathleen Smith, Md, MD
Dermatology — Payments: $90,662
Samuel Stahly
Dermatology — Payments: $5,744
Dr. Holly Hanson, Md, Phd, MD, PHD
Dermatology — Payments: $3,738
Joanne Mcalvany, Md, MD
Dermatology — Payments: $3,014
Damon Mauldin, Md, MD
Dermatology — Payments: $1,583
Novie Sroa, Md, MD
Dermatology — Payments: $1,368